(Q43279453)
Statements
1 reference
The role of KRAS mutations in predicting the efficacy of cetuximab-plus-irinotecan therapy in irinotecan-refractory Korean metastatic colorectal cancer patients (English)
1 reference
Byeong Seok Sohn
1 reference
Tae Won Kim
1 reference
Jae-Lyun Lee
1 reference
Min-Hee Ryu
1 reference
Heung Moon Chang
1 reference
Yoon-Koo Kang
1 reference
Hyo Suk Park
1 reference
Young-Soon Na
1 reference
Se Jin Jang
1 reference
Jin Cheon Kim
1 reference
Jung Shin Lee
1 reference
7 September 2009
1 reference
Identifiers
1 reference